Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin Descours

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Nature|March 16, 2017
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent provirusesBenjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Nature|June 29, 2017
Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent provirusesBenjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Immunity|November 13, 2012
Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cellsDarragh Duffy, Hélène Perrin, Valérie Abadie, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2012
HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirsSlim Fourati, Sidonie Lambert-Niclot, Cathia Soulie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 1, 2013
Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patientsBenjamin Descours, Sidonie Lambert-Niclot, Benoît Mory, et al.
Biochemical Pharmacology|February 7, 2016
Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cellsMercedes Bermejo, María Rosa López-Huertas, Javier García-Pérez, et al.
Blood Advances|December 12, 2018
Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphomaChia-Ching Wang, Cassandra Thanh, Erica A Gibson, et al.
Plos Pathogens|March 22, 2013
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI StudyAsier Sáez-Cirión, Charline Bacchus, Laurent Hocqueloux, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Nature|March 16, 2017
CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent provirusesBenjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Nature|June 29, 2017
Corrigendum: CD32a is a marker of a CD4 T-cell HIV reservoir harbouring replication-competent provirusesBenjamin Descours, Gaël Petitjean, José-Luis López-Zaragoza, et al.
Immunity|November 13, 2012
Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cellsDarragh Duffy, Hélène Perrin, Valérie Abadie, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2012
HIV-1 genome is often defective in PBMCs and rectal tissues after long-term HAART as a result of APOBEC3 editing and correlates with the size of reservoirsSlim Fourati, Sidonie Lambert-Niclot, Cathia Soulie, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 1, 2013
Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patientsBenjamin Descours, Sidonie Lambert-Niclot, Benoît Mory, et al.
Biochemical Pharmacology|February 7, 2016
Dasatinib inhibits HIV-1 replication through the interference of SAMHD1 phosphorylation in CD4+ T cellsMercedes Bermejo, María Rosa López-Huertas, Javier García-Pérez, et al.
Blood Advances|December 12, 2018
Transient loss of detectable HIV-1 RNA following brentuximab vedotin anti-CD30 therapy for Hodgkin lymphomaChia-Ching Wang, Cassandra Thanh, Erica A Gibson, et al.
Plos Pathogens|March 22, 2013
Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI StudyAsier Sáez-Cirión, Charline Bacchus, Laurent Hocqueloux, et al.
Pageof 2